XWELL Current Deferred Revenue (Quarterly) Analysis

XWELL, Inc. (XWEL)

0.3452 +0.01 (+2.86%) USD | NASDAQ | Jan 23, 16:00

0.325 -0.02 (-5.85%) Pre-Market: 20:00

View Current Deferred Revenue (Quarterly) for XWEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

FONAR Corp.	Upgrade
ProPhase Labs, Inc.	Upgrade
Veracyte, Inc.	Upgrade
Insight Molecular Diagnostics, Inc.	--
Exagen, Inc.	Upgrade